Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glipkul-M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Akul Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glipkul-M 1 Tablet SR

DiaGlyce-Duo 1mg Extended Release tablet is an antidiabetic medication combining two active agents for adult type 2 diabetes management. It regulates blood glucose levels. Always take DiaGlyce-Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms such as sweating, dizziness, headache, and tremor, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your doctor about any history of heart disease before starting this medication, as it may be unsuitable. Pregnant or breastfeeding individuals require physician consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to check blood cell counts and liver function.

Uses of Glipkul-M 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glipkul-M 1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glipkul-M 1 Tablet SR should be administered with a meal.

Common Side effects of Glipkul-M 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glipkul-M 1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the entire tablet; do not crush, chew, or break it. Consume Glipkul-M 1 Tablet SR with a meal.

How Glipkul-M 1 Tablet SR works:

Glipkul-M SR, a single-tablet formulation, combines glimepiride and metformin to manage type 2 diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glipkul-M 1 Tablet SR with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glipkul-M 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glipkul-M tablets (1 mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glipkul-M 1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glipkul-M 1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose of Glipkul-M 1 Tablet SR is typically prescribed for those with mild to moderate liver disease; its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glipkul-M 1 Tablet SR :

Should you forget a dose of Glipkul-M 1 Tablet SR, take it immediately if remembered. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glipkul-M 1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glipkul-M 1 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glipkul-M 1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glipkul-M 1 Tablet SR and seek immediate medical attention.
Glipkul-M 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glipkul-M 1 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glipkul-M 1 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Glipkul-M 1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glipkul-M 1 Tablet SR with alcohol is unsafe. Alcohol can exacerbate Glipkul-M's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glipkul-M 1 Tablet SR
30
MRP 35
14% off